Related Experiment Video
Updated: May 12, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Association of ficolin-3 with severity and outcome of chronic heart failure
Zoltán Prohászka1, Lea Munthe-Fog, Thor Ueland
1IIIrd Department of Internal Medicine, Semmelweis University, and Research Group of Inflammation Biology and Immunogenomics, Hungarian Academy of Sciences, Budapest, Hungary.
Insights
Low levels of ficolin-3, a key complement pathway initiator, are linked to advanced heart failure and increased mortality risk. This finding highlights ficolin-3
Area of Science:
- Immunology
- Cardiology
- Complement System
Background:
- Complement activation plays a role in heart failure pathophysiology.
- Initiating mechanisms of complement activation in heart failure remain unclear.
- Mannose-binding lectin (MBL), ficolin-2, and ficolin-3 are key initiators of the lectin complement pathway.
Purpose of the Study:
- To investigate the association of MBL, ficolin-2, and ficolin-3 with disease severity and outcome in chronic heart failure.
- To determine if these lectin pathway initiators are related to clinical parameters and mortality in heart failure patients.
Main Methods:
- Plasma concentrations of MBL, ficolin-2, and ficolin-3 were measured in two independent cohorts of heart failure patients and controls.
- Disease severity (NYHA class) and clinical parameters (BNP) were assessed at baseline.
- All-cause mortality was tracked over a 5-year follow-up period.
- Univariate and multivariable Cox regression analyses were performed.
Main Results:
- Low ficolin-3 levels, but not MBL or ficolin-2, were significantly associated with advanced heart failure (NYHA Class IV).
- Decreased ficolin-3 inversely correlated with B-type natriuretic peptide (BNP) levels.
- Low plasma ficolin-3 was a significant independent predictor of 5-year mortality.
- Reduced ficolin-3 levels correlated with increased complement activation (C3a) and decreased complement factor C3.
Conclusions:
- Low ficolin-3 levels are associated with advanced heart failure.
- Findings from two independent cohorts consistently show that low ficolin-3 levels predict poor outcome in heart failure.
- Decreased ficolin-3 is linked to heightened complement activation in the context of heart failure.
Background:
Inflammatory mechanisms involving complement activation has been shown to take part in the pathophysiology of congestive heart failure, but the initiating mechanisms are unknown. We hypothesized that the main initiator molecules of the lectin complement pathway mannose-binding lectin (MBL), ficolin-2 and ficolin-3 were related to disease severity and outcome in chronic heart failure.
Methods And Results:
MBL, ficolin-2 and ficolin-3 plasma concentrations were determined in two consecutive cohorts comprising 190 patients from Hungary and 183 patients from Norway as well as controls. Disease severity and clinical parameters were determined at baseline, and all-cause mortality was registered after 5-years follow-up. In univariate analysis a low level of ficolin-3, but not that of MBL or ficolin-2, was significantly associated with advanced heart failure (New York Heart Association Class IV, p<0.001 for both cohorts) and showed inverse correlation with B- type natriuretic peptide (BNP) levels (r = -0.609, p<0.001 and r = -0.467, p<0.001, respectively). In multivariable Cox regression analysis, adjusted for age, gender and BNP, decreased plasma ficolin-3 was a significant predictor of mortality (HR 1.368, 95% CI 1.052-6.210; and HR 1.426, 95% CI 1.013-2.008, respectively). Low ficolin-3 levels were associated with increased complement activation product C3a and correspondingly decreased concentrations of complement factor C3.
Conclusions:
This study provides evidence for an association of low ficolin-3 levels with advanced heart failure. Concordant results from two cohorts show that low levels of ficolin-3 are associated with advanced heart failure and outcome. The decrease of ficolin-3 was associated with increased complement activation.
Related Concept Videos
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure VII: Nursing Interventions
Acute Coronary Syndrome III: Diagnostic Studies